Oct. 31, 2019: HCV treatment efficacy regardless of injection drug use; chronic pain, marijuana, and prescription opoids; the most urgent HIV training priorities; neuro effects of switching from Atripla to Complera.
But other research links prisons themselves to mental health challenges and infectious disease outbreaks.
Authors of a literature review note the high prevalence of liver disease among people with HIV and recommend a step-by-step approach to management.
When people living with HIV are admitted to a hospital, they may not be able to bring their medications with them, and could be prescribed new medication by a doctor who doesn't understand their complete medical history.
Two models, one from Washington State and another from Los Angeles County, can be duplicated elsewhere to get people into care, experts say.
Alternate PrEP guideline recommendations; partner notification and onward HIV transmission; shifting causes of death among HIV/HCV-coinfected people; correlates of lower adherence among people on methadone maintenance.
A cellphone attachment that detects HIV RNA; HIV-2 does indeed often progress to AIDS; CD4 count declines and incident hepatitis C coinfection; the global demographics of non-Hodgkin lymphoma.
Despite being cured of hepatitis C, "patients with advanced liver disease may still be at considerable risk of [developing symptoms associated with cirrhosis] and liver cancer," according to researchers in the Target Consortium.
HIV/HCV-coinfected patients in a French cohort had 60% lower odds of insulin resistance, according to a large longitudinal analysis, with almost half of them having insulin resistance and almost half reporting marijuana use.
The Institute of Medicine (IOM) estimates that around 100 million Americans have pain. Compare this to the three million Americans living with hepatitis C (HCV). How do you know if HCV or something else is causing the pain?